| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/26/2011 | CN101953903A Mouthwash for treating gingivitis of children and preparation method thereof |
| 01/26/2011 | CN101953902A Pharmaceutical composition for postoperative recovery of chemoradiation |
| 01/26/2011 | CN101953897A Methods for preparing oral Chinese patent tablets and pills for treating gastric ulcer |
| 01/26/2011 | CN101953893A Traditional Chinese medicine for treating cirrhosis |
| 01/26/2011 | CN101953891A Chinese medicament for treating hepatocirrhosis |
| 01/26/2011 | CN101953884A Fingerprint quality detection method for medicinal composition |
| 01/26/2011 | CN101953883A Chinese medicinal granules for treating calculosis and preparation method thereof |
| 01/26/2011 | CN101953871A Antibacterial medicament for animals and preparation method and application thereof |
| 01/26/2011 | CN101953861A Chinese medicinal composition for treating hepatic fibrosis and preparation method |
| 01/26/2011 | CN101953847A Application of zinc hydroxide in preparation of anti-cancer drugs |
| 01/26/2011 | CN101953845A Transcatheter arterial chemoembolization embolism agent containing autophagy inhibitor |
| 01/26/2011 | CN101953812A Lansoprazole enteric coated tablet and preparation method thereof |
| 01/26/2011 | CN101953802A Lansoprazole enteric preparation and preparation method thereof |
| 01/26/2011 | CN101953800A Technology for producing water-soluble coenzyme Q10 and mannitol composite powder |
| 01/26/2011 | CN101953799A Lamivudine powder and preparation method thereof |
| 01/26/2011 | CN101953794A Silibinin injection and preparation method thereof |
| 01/26/2011 | CN101953791A Capsule containing cefprozil liposome and preparation method thereof |
| 01/26/2011 | CN101953790A Granules comprising cefprozil lipidosome and preparation method thereof |
| 01/26/2011 | CN101953789A Dry suspension containing cefprozil liposome and preparation method thereof |
| 01/26/2011 | CN101953788A Cefprozil liposome-containing dispersible tablet and preparation method thereof |
| 01/26/2011 | CN101953787A Tablet containing cefprozi liposome and preparation method thereof |
| 01/26/2011 | CN101953773A Lamivudine liposome solid preparation |
| 01/26/2011 | CN101953516A Nanometer element anion far infrared antibacterial textile underwear for modern civil diseases |
| 01/26/2011 | CN101953496A Lithiasis recovery drinks |
| 01/26/2011 | CN101664540B Orally-taken traditional Chinese medicine preparation used for aquiculture and preparation method thereof |
| 01/26/2011 | CN101584841B Gardenia-rhubarb soup for treating acute cholecystitis |
| 01/26/2011 | CN101559106B Medicament for treating gastritis |
| 01/26/2011 | CN101530399B Silibinin solid self-emusifying tablet |
| 01/26/2011 | CN101502632B Chinese medicine for cholecystitis |
| 01/26/2011 | CN101496787B Prostaglandin E1 lipid microsphere injection with charge effect and preparation method thereof |
| 01/26/2011 | CN101474165B Polynucleotide microcapsule for treating diseases of livestock and poultry and preparation method thereof |
| 01/26/2011 | CN101444578B A traditional Chinese medicine for the treatment of hepatitis |
| 01/26/2011 | CN101439137B External-use Chinese medicinal composition for toothache |
| 01/26/2011 | CN101433581B Pharmaceutical composition and its uses |
| 01/26/2011 | CN101417116B Decoction for treating urgent hepatitis with jaundice |
| 01/26/2011 | CN101396548B Medicine composition for treating chronic gastritis |
| 01/26/2011 | CN101391078B Internal medicine for treating fatty liver |
| 01/26/2011 | CN101385837B Chinese prepared medicine for treating gastrosis |
| 01/26/2011 | CN101361898B Chinese herbal medicine gargle for preventing and treating AIDS stomatitis |
| 01/26/2011 | CN101348799B Construction method and pharmaceutical use of microRNA adenovirus expression plasmid for severe hepatitis related gene hfg12, hFas and hTNFR1 |
| 01/26/2011 | CN101347527B Chinese medicine for treating hepatocirrhosis |
| 01/26/2011 | CN101342338B Medicament for treating hepatopathy |
| 01/26/2011 | CN101336682B Honey beverage and preparation method thereof |
| 01/26/2011 | CN101259082B Root canal anti-inflammation developing agent and preparation thereof |
| 01/26/2011 | CN101019966B Tonic wine with brain nourishing, Yang strengthening and other function and its prepn process |
| 01/26/2011 | CN101019945B Hepatitis treating Chinese medicine composition soft capsule |
| 01/26/2011 | CN101007082B A health mongolian veterinary drug |
| 01/26/2011 | CN101002849B Traditional Chinese medicine extractive or tablet for treating hepatitis, and its preparing method |
| 01/26/2011 | CN101002827B Micro-emulsion of mint oil with slow-releasing property, and its preparing method |
| 01/25/2011 | US7877129 Magnetic resonance imaging apparatus and RF reception coil apparatus |
| 01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/25/2011 | US7875585 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide |
| 01/25/2011 | US7875301 comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; treating neutropenia and aplastic anemia |
| 01/25/2011 | US7875292 Orally disintegrable tablets |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | CA2491836C 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder |
| 01/25/2011 | CA2490141C 1-[(indol-3-yl)carbonyl]piperazine derivatives |
| 01/25/2011 | CA2477557C Stabilized albumin preparations |
| 01/25/2011 | CA2476983C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
| 01/25/2011 | CA2463146C Crystalline sodium salt of telmisartan and the use of same as an angiotensin antagonist |
| 01/25/2011 | CA2458690C Pharmaceutical compositions comprising an ascomycin derivative |
| 01/25/2011 | CA2447765C 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 01/25/2011 | CA2441834C Lipid profile modulation |
| 01/25/2011 | CA2434299C Tricyclic androgen receptor modulator compounds and methods |
| 01/25/2011 | CA2432582C Sulfamidothienopyrimidines |
| 01/25/2011 | CA2410233C Compounds for treating impaired fundic relaxation |
| 01/25/2011 | CA2388468C Mediators of hedgehog signalling pathways, compositions and uses related thereto |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/25/2011 | CA2334200C Pyrrolo[2,3d]pyrimidine compositions and their use |
| 01/25/2011 | CA2317455C Hydroxamic and carboxylic acid derivatives |
| 01/20/2011 | WO2011009075A2 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 01/20/2011 | WO2011008640A1 Methods of increasing liver proliferation |
| 01/20/2011 | WO2011008112A1 Application of natural mineral water with special qualities in prophylaxis, hygiene and treatment of teeth and paradontium. |
| 01/20/2011 | WO2011007807A1 Method for manufacturing spilanthol and intermediate manufacturing product therefor |
| 01/20/2011 | WO2011007794A1 Zeolite and sericite-containing composition for medical or medical assisting uses |
| 01/20/2011 | WO2011007722A1 3-substituted-2-furancarboxylic acid hydrazide derivative and pharmaceutically acceptable salt thereof |
| 01/20/2011 | WO2011007633A1 Crystals of pyrroloquinolinequinone sodium salts |
| 01/20/2011 | WO2011007612A1 Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application |
| 01/20/2011 | WO2011007584A1 Prophylactic, ameliorating or therapeutic agent for oral diseases |
| 01/20/2011 | WO2011007552A1 Bad breath-removing agent |
| 01/20/2011 | WO2011007551A1 Sugar alcohol-containing antibacterial agent for inhibiting proliferation of periodontal disease-causing bacteria |
| 01/20/2011 | WO2011006938A1 Use of proanthocyanidins for production of an antiadhesive preparation |
| 01/20/2011 | WO2011006263A1 Antibacterial oral composition |
| 01/20/2011 | WO2011006252A1 Method of processing cereal grain with lactic acid for use in ruminant feed |
| 01/20/2011 | WO2010133359A3 The improvement of gastrointestinal health, immunity and performance by dietary intervention |
| 01/20/2011 | WO2003034984A9 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 01/20/2011 | US20110015663 Combination Therapies for the Treatment of Obesity |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015268 Pharmaceutical composition |
| 01/20/2011 | US20110015239 Inhibitors of calcium-activated chloride channels |
| 01/20/2011 | US20110015234 Indazole derivatives |
| 01/20/2011 | US20110015233 Stable Pharmaceutical Omeprazole Formulation for Oral Administration |
| 01/20/2011 | US20110015230 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 01/20/2011 | US20110015226 Treatment of Energy Utilization Disease |
| 01/20/2011 | US20110015212 Pyrimidinones as pi3k inhibitors |
| 01/20/2011 | US20110015211 Fibrosis inhibitor |
| 01/20/2011 | US20110015198 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |
| 01/20/2011 | US20110015191 Organic compounds |